Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace ...

Government signs deal to see huge investment in mRNA vaccine manufacturing which could help tackle the next pandemic and ...

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

Coupled with AI-driven design and optimization, researchers can now rapidly fine-tune mRNA structures for improved stability and efficacy. These advancements have propelled mRNA technology forward, ...

It's an mRNA-based vaccine that is called multicomponent ... This is a look at whether an AI-driven model is able to take a look at people's retinas and determine whether they have kidney disease ...

IntroductionThe global vaccines market has witnessed unprecedented growth in recent years, driven by technological ...

A new PEARLS article in PLoS Pathogens reviews the rapid evolution and pandemic potential of emerging influenza A viruses, ...

Clarivate Plc (NYSE:CLVT) launched RiskMark, an AI-driven trademark risk evaluation tool combining CompuMark trademark data ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7% in the afternoon session after the FDA announced new ...